Co-managing laser cataract surgery

Article

Katherine M. Mastrota, OD, offers her view on one panelist’s presentation during the special session “Refractive/Cataract Surgery: The Future Revealed” at the 90th annual SECO International meeting in Atlanta.

Associate Optometric Editor Katherine M. Mastrota, OD, offers her view on one panelist’s presentation during the special session “Refractive/Cataract Surgery: The Future Revealed” at the 90th annual SECO International meeting in Atlanta:

Former Wills Eye Hospital surgeon Tyrie Jenkins, MD, spoke about her perspective on femtosecond laser cataract surgery, the implications of laser cataract surgery and OD cataract surgery co-management as part of a panel.

Dr. Jenkins, who is based in Honolulu, is a proponent of OD/MD cataract surgery co-management. She reviewed cataract surgery from couching to what may become the standard in cataract surgery today, laser-assisted cataract surgery. Laser-assisted cataract surgery has the potential to improve refractive outcomes and reduce cataract complications by creating a precise corneal incision and capsulorhexis as well as pre-treating the natural lens for removal with less phacoemulsification power.

The femtosecond photodisruptive laser produces microscopic bubbles that have the ability to divide material at a molecular level with no heat production. Interestingly, Dr. Jenkins notes that patient adoption of laser-assisted cataract surgery, currently an upcharge, is at 45% in her practice.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.